The Latest
-
This ASX biotech is pushing for a Nasdaq listing. Could it reignite investor interest?
-
3 ASX 200 shares just upgraded to strong buy — here’s what the brokers are saying
-
2 ASX ETFs up 35% or more in 2026
-
These 4 ASX 200 shares have slumped to fresh 52-week lows: Buy, sell or hold?